Shine-On BioMedical Co.,Ltd. (TPEX:6926)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
68.90
-0.70 (-1.01%)
Feb 11, 2026, 1:05 PM CST
Market Cap3.46B +4.0%
Revenue (ttm)n/a
Net Income-117.07M
EPS-2.36
Shares Out49.80M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume12,751
Average Volume12,031
Open69.60
Previous Close69.60
Day's Range67.00 - 69.60
52-Week Range57.00 - 81.60
Beta-0.03
RSI49.59
Earnings DateNov 14, 2025

About Shine-On BioMedical

Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. Shine-On BioMedical Co.,Ltd. was founded in 2011 and is based in Taichung, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 22
Stock Exchange Taipei Exchange
Ticker Symbol 6926
Full Company Profile

Financial Performance

Financial Statements